Poly(ADP-ribose) polymerase-1 gene in human tumor cell lines: Its expression and structural alteration

被引:5
|
作者
Masutani, M
Nozaki, T
Sasaki, H
Yamada, T
Kohno, T
Shimizu, K
Gotoh, M
Shiraishi, M
Yokota, J
Hirohashi, S
Nakagama, H
Sugimura, T
机构
[1] Natl Canc Ctr, Div Biochem, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Div Genet, Chuo Ku, Tokyo 1040045, Japan
[3] Natl Canc Ctr, Expt Pathol & Chemotherapy Div, Chuo Ku, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Div Biol, Chuo Ku, Tokyo 1040045, Japan
[5] Natl Canc Ctr, Div Mol Oncol, Chuo Ku, Tokyo 1040045, Japan
[6] Natl Canc Ctr, Div Pathol, Chuo Ku, Tokyo 1040045, Japan
[7] Natl Canc Ctr, DNA Methylat & Genome Funct Project, Chuo Ku, Tokyo 1040045, Japan
关键词
poly(ADP-ribose) polymerase-1; tumor cell line; gene expression; structural alteration;
D O I
10.2183/pjab.80.114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Poly(ADP-ribose) polymerase-1 (Parp-1) is involved in DNA repair and cell-death induction after DNA damage. Parp-1(-/-) mice show higher susceptibility to the carcinogenic effects of nitrosamine and azoxymethane. To elucidate the role of alterations of the PARP-1 gene in human carcinogenesis, we examined the expression level of PARP-1 gene in various human tumor cell lines. The presence of gross rearrangement of PARP-1 gene in these cell lines was also examined by Southern blot hybridization analysis. The expression levels of PARP-1 gene in several cell lines, including T-cell leukemia cell lines (Molt-4 and CCRF-CEM), colon cancer cell line (WiDr), and gastric cancer cell lines (KATOIII, OKAJIMA, and MKN45) was substantially lower than in other cancer cell lines. Among the 85 analyzed cell lines, structural alteration of PARP-1 gene was detected in a gastric cancer cell line, MKN28. A low level of PARP-1 expression in human cancer could potentially influence cancer cell growth, differentiation and cancer development by affecting genomic instability, as well as the response of tumors to chemo- and radiotherapy.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 50 条
  • [31] Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain
    Poitras, M. F.
    Koh, D. W.
    Yu, S.-W.
    Andrabi, S. A.
    Mandir, A. S.
    Poirier, G. G.
    Dawson, V. L.
    Dawson, T. M.
    NEUROSCIENCE, 2007, 148 (01) : 198 - 211
  • [32] Poly ADP-ribose polymerase-1: An international molecule of mystery
    Woodhouse, Bethany C.
    Dianov, Grigory L.
    DNA REPAIR, 2008, 7 (07) : 1077 - 1086
  • [33] Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis
    Safdar, Raishal
    Mishra, Aastha
    Shah, Girish M.
    Ashraf, Mohammad Zahid
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (05) : 743 - 753
  • [34] The role of poly(ADP-ribose) polymerase-1 in CNS disease
    Kauppinen, T. M.
    Swanson, R. A.
    NEUROSCIENCE, 2007, 145 (04) : 1267 - 1272
  • [35] The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis
    Garcia, Samuel
    Conde, Carmen
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [36] Poly(ADP-ribose) polymerase-1 as a target for drug development
    Masutani, Mitsuko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 31P - 31P
  • [37] Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1
    Amiri, K. I.
    Ha, H. C.
    Smulson, M. E.
    Richmond, A.
    ONCOGENE, 2006, 25 (59) : 7714 - 7722
  • [38] Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines
    Nasuno, Tomomitsu
    Mimaki, Sachiyo
    Okamoto, Makito
    Esumi, Hiroyasu
    Tsuchihara, Katsuya
    CANCER SCIENCE, 2014, 105 (02) : 202 - 210
  • [39] Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications
    Sodhi, Rupinder K.
    Singh, Nirmal
    Jaggi, Amteshwar S.
    VASCULAR PHARMACOLOGY, 2010, 53 (3-4) : 77 - 87
  • [40] Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1
    K I Amiri
    H C Ha
    M E Smulson
    A Richmond
    Oncogene, 2006, 25 : 7714 - 7722